Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice -HOPE

NCT03155243 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03155243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03155243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice -HOPE
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
June 20, 2017
Completion date
February 24, 2020
Enrollment
155 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis